Taisho Deal Gives BioAge First Clinical Asset
HIF-PHI Targets Aging Disorders
Private US venture moves into the clinic with early-stage asset from Japanese partner with potential in aging disorders.
Private US venture moves into the clinic with early-stage asset from Japanese partner with potential in aging disorders.